Eads & Heald Wealth Management’s Southwest Airlines LUV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,880
Closed -$213K 144
2023
Q2
$213K Sell
5,880
-2,299
-28% -$72.1K 0.1% 142
2023
Q1
$266K Buy
8,179
+868
+12% +$29.5K 0.13% 130
2022
Q4
$246K Sell
7,311
-4,450
-38% -$160K 0.13% 136
2022
Q3
$363K Sell
11,761
-6,770
-37% -$254K 0.21% 117
2022
Q2
$669K Buy
18,531
+10,857
+141% +$467K 0.36% 100
2022
Q1
$351K Buy
+7,674
New +$337K 0.16% 121
2020
Q1
Sell
-5,616
Closed -$303K 125
2019
Q4
$303K Sell
5,616
-575
-9% -$31.9K 0.16% 118
2019
Q3
$334K Hold
6,191
0.19% 113
2019
Q2
$314K Sell
6,191
-300
-5% -$15.5K 0.18% 115
2019
Q1
$337K Buy
6,491
+416
+7% +$21.9K 0.2% 113
2018
Q4
$282K Sell
6,075
-4,977
-45% -$264K 0.19% 114
2018
Q3
$690K Buy
11,052
+870
+9% +$50.9K 0.4% 96
2018
Q2
$518K Sell
10,182
-1,010
-9% -$53.2K 0.32% 103
2018
Q1
$641K Buy
11,192
+4,073
+57% +$245K 0.41% 96
2017
Q4
$466K Buy
+7,119
New +$419K 0.27% 108

Other funds holding LUV

Eads & Heald Wealth Management's LUV Position: Q3 2023 in Review

Eads & Heald Wealth Management sold out of Southwest Airlines (LUV) in Q3 2023, closing a stake of 5,880 shares — an estimated $213K sold.

Eads & Heald Wealth Management first reported a position in LUV in Q4 2017 and held it in 15 quarters. The position peaked at $690K in Q3 2018. 766 funds tracked by Wall St. Rank hold LUV as of Q3 2023.

  • Eads & Heald Wealth Management reported no remaining Southwest Airlines position as of Q3 2023 after selling out during the quarter.
  • Eads & Heald Wealth Management sold 5,880 Southwest Airlines shares in Q3 2023, an estimated $213K.
  • Eads & Heald Wealth Management first reported a position in Southwest Airlines in Q4 2017 and held it in 15 quarters.
  • Eads & Heald Wealth Management's Southwest Airlines position peaked at $690K in Q3 2018.
  • 766 funds tracked by Wall St. Rank held Southwest Airlines as of Q3 2023.

Based on Eads & Heald Wealth Management's 13F filing for Q3 2023, filed 27 Oct 2023.